These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32063481)

  • 21. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
    Kuroshima S; Sasaki M; Murata H; Sawase T
    Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
    Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
    Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-antiresorptive drugs associated with the development of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis.
    Suryani IR; Ahmadzai I; Shujaat S; Ma H; Jacobs R
    Clin Oral Investig; 2022 Mar; 26(3):2269-2279. PubMed ID: 35013781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Miranda M; Gianfreda F; Raffone C; Antonacci D; Pistilli V; Bollero P
    Biomed Res Int; 2021; 2021():4948139. PubMed ID: 34095295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study.
    Parise GK; Costa BN; Nogueira ML; Sassi LM; Schussel JL
    Oral Maxillofac Surg; 2023 Sep; 27(3):507-512. PubMed ID: 35739366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment methods of medication-related osteonecrosis of the jaw. A systematic review.
    Zigmantavičius J; Kilinskaitė G; Kubilius R
    Stomatologija; 2022; 24(4):91-99. PubMed ID: 37154420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.
    Alrmali A; Saleh MHA; Kurdi SMS; Sabri H; Meghil MM; Wang HL
    Clin Exp Dent Res; 2023 Oct; 9(5):791-798. PubMed ID: 37605488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study.
    Jamalpour MR; Shahabi S; Baghestani M; Shokri A; Jamshidi S; Khazaei S
    BMC Oral Health; 2022 Jun; 22(1):241. PubMed ID: 35717177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents.
    Rodriguez-Lozano FJ; Oñate-Sánchez RE
    Med Oral Patol Oral Cir Bucal; 2016 Sep; 21(5):e595-600. PubMed ID: 27475683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T
    Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.
    Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun; 131(6):650-659. PubMed ID: 33518491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.
    Khominsky A; Lim M
    Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.
    Fliefel R; Tröltzsch M; Kühnisch J; Ehrenfeld M; Otto S
    Int J Oral Maxillofac Surg; 2015 May; 44(5):568-85. PubMed ID: 25726090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature.
    Kanwar N; Bakr MM; Meer M; Siddiqi A
    Br Dent J; 2020 Jun; 228(11):886-892. PubMed ID: 32541753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of developing spontaneous MRONJ in fibrous dysplasia patients treated with bisphosphonates: a systematic review of the literature.
    Nadella S; Mupparapu M; Akintoye SO
    Quintessence Int; 2022 Jun; 53(7):616-623. PubMed ID: 35674165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: Case series and literature review.
    Escobedo MF; Cobo JL; Junquera S; Milla J; Olay S; Junquera LM
    J Stomatol Oral Maxillofac Surg; 2020 Feb; 121(1):40-48. PubMed ID: 31035023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in the Knowledge and Experience of Physicians and Dentists About Medication-Related Osteonecrosis of the Jaw in Osteoporotic Patients.
    Yamori M; Tamura M; Mikami M; Mori T; Noi M; Machida Y; Koshinuma S; Yamamoto G
    Int Dent J; 2021 Aug; 71(4):336-342. PubMed ID: 33518370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.